無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

NIPT (非侵襲的出生前検査) 検査の世界市場

Global Non-Invasive Prenatal Testing (NIPT) Market - Analysis and Forecast 2017-2023: Focus on Test Type, Country Analysis (Test Volume & Value), APAC Countries by Test Type, Patent Landscape and Competitive Landscape

発行 BIS Research Inc. 商品コード 498155
出版日 ページ情報 英文 224 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.70円で換算しております。
Back to Top
NIPT (非侵襲的出生前検査) 検査の世界市場 Global Non-Invasive Prenatal Testing (NIPT) Market - Analysis and Forecast 2017-2023: Focus on Test Type, Country Analysis (Test Volume & Value), APAC Countries by Test Type, Patent Landscape and Competitive Landscape
出版日: 2017年04月30日 ページ情報: 英文 224 Pages
概要

当レポートでは、世界のNIPT (非侵襲的出生前検査) 検査市場について分析し、検査方法の概略や主な利点・欠点、主な市場促進・抑制要因、関連疾患の概要、市場規模の動向見通し (検査方法別・地域別)、市場競争の現状と方向性、主要企業のプロファイルなどを調査しております。

第1章 分析範囲・手法

第2章 市場概要

  • イントロダクション
  • NIPTの利点とリスク
  • NIPTの技術的アプローチ
    • FCMB (母体血液中胎児細胞検査)
    • 無細胞NIPT検査
  • 特許環境
  • 世界の出生前検査市場の将来展望

第3章 市場のダイナミクス

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 主な染色体異数性

第5章 競争環境

  • 市場の主な動向と戦略
  • 市場求心力の分析:地域別
  • 成長率シェア・マトリックス
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第6章 世界のNIPT市場:検査手法別 (数量・金額ベース)

  • 市場概要
  • Panorama検査
  • Sequenom検査
  • Harmony検査
  • NIFTY検査
  • verifi検査
  • IONA検査
  • Prena検査
  • BambniTest
  • その他

第7章 世界のNIPT市場:地域別 (数量・金額ベース)

  • 地域別の市場シナリオ
  • 北米
  • 欧州
  • アジア太平洋地域
  • 他の国々 (RoW)

第8章 エンドユーザー側の認識

第9章 企業プロファイル

目次
Product Code: MD20

North America was the largest market for NIPT in 2016 in terms of revenue and volume. The region is expected to retain its leadership position throughout the forecast period as major players in the NIPT market are based in the U.S. (the largest shareholder in North America).

Non-invasive prenatal testing (NIPT) is an innovative way of screening pregnancies for fetal chromosomal aneuploidies by analyzing fetal cell-free DNA circulating in maternal blood. Amniocentesis, chorionic villus sampling (CVS), maternal serum screening, and nuchal translucency (NT) scan have been the primary diagnostic and screening methods for chromosomal abnormalities. The growth of NIPT market is attributed primarily to a rapid increase in genetic disorders/abnormalities, increase in fetal mortality, adoption of NIPT test in developed countries, and advancement of healthcare technologies.

In spite of enormous competition levels that prevails in the industry, the market growth is expected to be propelled by multiple factors such as rising demand for prenatal testing, adoption toward IVF procedures, increasing awareness among parents, and upsurge in the government spending on healthcare.

The research study has segmented the entire NIPT market into test value and volume, and geographical region including detail country analysis which enables the user gain a multi-dimensional view of the market. The research report employs an exhaustive and analytical approach to estimate and understand the market thus provides an all-inclusive insight into various forms of developments, market trends and strategies. While underlining the key driving and restraining factors for the NIPT market, the report also provides a comprehensive understanding in terms of competitive landscape, market share analysis, competitor benchmarking (matrices), and their positioning within the global NIPT market.

The following questions have been answered in this report:

  • What are the major market drivers, challenges and opportunities of the global NIPT market and their use cases?
  • What are the key technological developments taking place in the NIPT market?
  • What is the market share of the leading segments and sub-segments of the global NIPT market during the forecast period (2017-2023)?
  • How will each segment of the global NIPT market grow over the forecast period and the revenue share for each of them by the end of 2023?
  • Who are the leading players in the global NIPT market (2016)?
  • Which geographical region will have the highest growth rate (CAGR) during the forecast period?
  • What are the key development strategies employed by the key players across various geographies?
  • What are the market trends and key developments in different geographical regions?
  • What is the role of various regulatory and governmental agencies in global NIPT market across various geographical locations?
  • What are the major consumer preferences while purchasing or undergoing an NIPT test?

The report includes the company profiles for leading players in the NIPT market which enables the readers understand the current competitive scenario that prevails in this industry. Some of the key player include Roche, Natera, Illumina, LabCorp, LifeCodexx, BGI Diagnostics, Premaitha and Berry Genomics, among others.

Table of Contents

Executive Summary

1. Report Scope & Methodology

  • 1.1. Scope of the Report
  • 1.2. Global NIPT Market Segmentation
  • 1.3. Key Learnings
  • 1.4. Research Methodology
    • 1.4.1. Data Triangulation
    • 1.4.2. Key Data Points from Secondary Sources
    • 1.4.3. Key Data Points from Primary Sources
    • 1.4.4. Top-Down Approach (Segment Analysis)
    • 1.4.5. Bottom-Up-Approach (Segment Analysis)
    • 1.4.6. Assumptions and Limitations
    • 1.4.7. Data and Prediction Modelling

2. Market Overview

  • 2.1. Introduction
  • 2.2. Benefits and Risks of NIPT
  • 2.3. Technological Approach for NIPT
    • 2.4.1. Fetal Cell Maternal Blood (FCMB)
    • 2.4.2. Cell-Free NIPT Test
  • 2.5. Patent Landscape
  • 2.6. World Economic Outlook of Prenatal Testing Market, 2016

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

4. Major Chromosomal Aneuploidies

5. Competitive Landscape

  • 5.1. Key Developments & Strategies
  • 5.2. Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
  • 5.3. Growth Share Matrix
  • 5.4. Porter's Five Forces Analysis
  • 5.5. Value Chain Analysis

6. Global NIPT Market, By Test (Volume and Value)

  • 6.1. Market Overview
  • 6.2. Panorama Test
  • 6.3. Sequenom Test
  • 6.4. Harmony Test
  • 6.5. NIFTY Test
  • 6.6. verifi Test
  • 6.7. IONA Test
  • 6.8. Prena Test
  • 6.9. BambniTest
  • 6.1. Other NIPT Tests

7. Global NIPT Market, By Geography(Volume and Value)

  • 7.1. Geographical Scenario
  • 7.2. North America
  • 7.3. Europe
  • 7.4. Asia Pacific
  • 7.5. Rest of the World (RoW)

8. End User Perception

9. Company Profiles

  • 9.1. Laboratory Corporation of America
  • 9.2. Roche AG
  • 9.3. Premaitha Health Plc
  • 9.4. Illumina Inc.
  • 9.5. Natera Inc.
  • 9.6. Quest Diagnostics
  • 9.7. BGI Diagnostics
  • 9.8. LifeCodexx AG
  • 9.9. Berry Genomics
  • 9.10. NIPD Genetics

LIST OF FIGURES

  • 1 Global NIPT Market by Volume, 2016-2023 (in Units)
  • 2 Global NIPT Market Value, 2016-2023 ($Million)
  • 3 NIPT Market Value by Test Type, 2016
  • 4 NIPT Market Value by Test Type, 2023
  • 5 NIPT Market Volume by Test Type, 2016
  • 6 NIPT Market Volume by Test Type, 2023
  • 7 Global NIPT Market Value by Geography, 2016 & 2023 ($Million)
  • 8 Global NIPT Market Volume by Geography, 2016 & 2023 (in Units)
  • 9 Global NIPT Market Segmentation
  • 10 Research Methodology
  • 11 Data Triangulation
  • 12 Top-Down Approach (Segmental Analysis)
  • 13 Bottom-Up Approach (Segmental Analysis)
  • 14 Assumptions and Limitations
  • 15 NIPT: Overall Process
  • 16 Global Prenatal Testing Market: Opportunity Matrix
  • 17 Ecosystem Players Of Global Prenatal Testing Market
  • 18 Prenatal Testing Timeline During Pregnancy
  • 19 Market Dynamics
  • 20 Market Share Analysis, 2016
  • 21 Market Share Analysis, 2023
  • 22 Growth Share Matrix, 2016
  • 23 Porter's Five Forces Analysis
  • 24 Value Chain Analysis
  • 25 Panorama Test by Volume, 2016-2023 (in Units)
  • 26 Panorama Test by Value, 2016-2023 ($Million)
  • 27 Panorama Test Volume by Geography, 2016-2023 (in Units)
  • 28 Sequenom Test by Volume, 2016-2023 (in Units)
  • 29 Sequenom Test by Value, 2016-2023 ($Million)
  • 30 Sequenom Test Volume by Geography, 2016-2023 (in Units)
  • 31 Sequenom Test Value by Geography, 2016-2023 ($Million)
  • 32 Harmony Test by Volume, 2016-2023 (in Units)
  • 33 Harmony Test by Value, 2016-2023 ($Million)
  • 34 Harmony Test Volume by Geography, 2016-2023 (in Units)
  • 35 Harmony Test Value by Geography, 2016-2023 ($Million)
  • 36 NIFTY Test by Volume, 2016-2023 (in Units)
  • 37 NIFTY Test by Value, 2016-2023 ($Million)
  • 38 NIFTY Test Volume by Geography, 2016-2023 (in Units)
  • 39 NIFTY Test Value by Geography, 2016-2023 ($Million)
  • 40 verifi Test by Volume, 2016-2023 (in Units)
  • 41 verifi Test by Value, 2016-2023 ($Million)
  • 42 verifi Test Volume by Geography, 2016-2023 (in Units)
  • 43 verifi Test Value by Geography, 2016-2023 ($Million)
  • 44 IONA Test by Volume, 2016-2023 (in Units)
  • 45 IONA Test by Value, 2016-2023 ($Million)
  • 46 IONA Test Volume by Geography, 2016-2023 (in Units)
  • 47 IONA Test Value by Geography, 2016-2023 ($Million)
  • 48 Prena Test by Volume, 2016-2023 (in Units)
  • 49 Prena Test by Value, 2016-2023 ($Million)
  • 50 Prena Test Volume by Geography, 2016-2023 (in Units)
  • 51 Prena Test Value by Geography, 2016-2023 ($Million)
  • 52 BambniTest by Volume, 2016-2023 (in Units)
  • 53 BambniTest by Value, 2016-2023 ($Million)
  • 54 BambniTest Volume by Geography, 2016-2023 (in Units)
  • 55 BambniTest Value by Geography, 2016-2023 ($Million)
  • 56 Other NIPT Tests by Volume, 2016-2023 (in Units)
  • 57 Other NIPT Tests by Value, 2016-2023 ($Million)
  • 58 Other NIPT Tests Volume by Geography, 2016-2023 (in Units)
  • 59 Other NIPT Tests Value by Geography, 2016-2023 ($Million)
  • 60 NIPT Market Value by Geography, 2016-2023 ($Million)
  • 61 NIPT Market Volume by Geography, 2016-2023 (in Units)
  • 62 Key Factors Influencing Decision about NIPT Market
  • 63 Influence of GPs, Labs, and KOLs on Decision Making
  • 64 Willingness to Purchase NIPT Tests
  • 65 Technology Preferences
  • 66 Perception about Pricing
  • 67 Perception about Brand
  • 68 Selection Criteria for NIPT Tests
  • 69 Sources of Information about NIPT
  • 70 Information Required to Purchase a new Test
  • 71 Preferred Channel for Purchasing
  • 72 Laboratory Corporation of America Financials
  • 73 Roche AG Financials
  • 74 Premaitha Health Plc Financials
  • 75 Illumina Inc. Financials
  • 76 Natera Inc. Financials
  • 77 Quest Diagnostics Incorporated Financials

LIST OF FIGURES

  • 1 Table: Global Non-Invasive Prenatal Testing (NIPT) Market (2016 & 2023)
  • 2 Table: Technological Approach for NIPT
  • 3 Table: Patent Landscape
  • 4 Table: Types Of Genetic Diseases In Fetuses: An Overview
  • 5 Table: Major Chromosomal Aneuploidies and their Incidence Rate
  • 6 Table: Recent Partnerships & Collaborations
  • 7 Table: Recent Product Launch & Developments
  • 8 Table: Recent Merger & Acquisitions
  • 9 Table: Recent Patent , Certifications, Infringements & Approvals
  • 10 Table: Global NIPT Market Value by Test Type, 2016-2013 (In Units)
  • 11 Table: North America Market Scope Statistics
  • 12 Table: North America NIPT Market by Test Value, 2016-2023 ($Million)
  • 13 Table: Europe NIPT Market by Test Value, 2016-2023 ($Million)
  • 14 Table : Europe NIPT Market by Test Volume, 2016-2023 (in Units)
  • 15 Table: Europe NIPT Market by Country, 2016-2023 (in Units)
  • 16 Table: Europe: Recent Developments
  • 17 Table: APAC NIPT Market by Test Volume, 2016-2023 ($Million)
  • 18 Table: APAC NIPT Market by Test Value, 2016-2023 (in Units)
  • 19 Table : APAC NIPT Market by Country, 2016-2023 (in Units)
  • 20 Table: ROW NIPT Market by Test value, 2015-2023 (in Units)
  • 21 Table: ROW NIPT Market by Test Volume, 2015-2023 (in Units)
Back to Top